UPDATED Jan 02, 2026
Discover Hong Kong Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the HSI and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on 'Advanced Filters'.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
1177 | HK$6.36 | -0.9% | 107.8% | HK$113.7b | HK$9.57 | PE26.2x | E7.3% | 1.6% | ||
2096 | HK$11.80 | -7.6% | 70.8% | HK$30.6b | HK$16.11 | PE31.2x | E24.2% | 1.5% | ||
1530 | HK$24.58 | -5.0% | 315.9% | HK$61.4b | HK$38.55 | PE23.3x | E-12.9% | 1.0% | ||
3692 | HK$36.44 | -2.6% | 118.7% | HK$220.6b | HK$44.87 | PE41.4x | E12.1% | 1.0% | ||
2566 | HK$7.61 | 1.3% | 22.3% | HK$1.9b | n/a | PE13.6x | n/a | 0.8% | ||
570 | HK$2.12 | -1.9% | -5.4% | HK$10.7b | HK$1.50 | PB0.5x | S1.4% | 0.2% | ||
1498 | HK$0.35 | -4.1% | -37.5% | HK$187.3m | n/a | PB1.8x | n/a | 0% | ||
8247 | HK$2.28 | 1.3% | 200.0% | HK$329.9m | n/a | PS1.3x | n/a | 0% | ||
455 | HK$0.14 | 26.4% | -19.2% | HK$298.9m | n/a | PB0.6x | n/a | 0% | ||
1548 | HK$12.79 | -2.0% | 28.7% | HK$28.0b | HK$23.49 | PE784x | E92.9% | 0% | ||
6185 | HK$34.96 | -4.0% | 13.9% | HK$12.6b | HK$52.26 | PS8x | E114.2% | 0% | ||
897 | HK$0.39 | 0% | 56.0% | HK$438.8m | n/a | PB0.4x | n/a | 0% | ||
6118 | HK$0.89 | -5.3% | 56.1% | HK$456.2m | n/a | PE11.6x | n/a | 0% | ||
775 | HK$0.83 | -2.4% | 104.9% | HK$8.0b | n/a | PS1.5x | n/a | 0% | ||
1011 | HK$0.85 | -8.6% | 214.8% | HK$573.1m | n/a | PS27.5x | n/a | 0% | ||
1652 | HK$0.80 | 0% | 0% | HK$591.4m | n/a | PS2.2x | n/a | 0% | ||
1873 | HK$1.76 | -6.9% | 112.0% | HK$3.7b | HK$3.84 | PE19.3x | E-35.1% | 0% | ||
1643 | HK$0.51 | 0% | 41.7% | HK$367.2m | n/a | PE17.4x | n/a | 0% | ||
2186 | HK$2.77 | -2.1% | 30.7% | HK$11.1b | HK$3.59 | PE25x | E30.7% | 0% | ||
6887 | HK$44.64 | 2.2% | 26.1% | HK$25.7b | n/a | PE47.8x | n/a | 0% |